SCHEMBL6929477

SCHEMBL6929477

Nc1cccc2oc(Cc3ccccc3-n3cnnn3)nc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 10/20 0.59
F10 P00742 7/20 0.50
PLAT P00750 3/20 0.49
PRSS1 P07477 3/20 0.49
PRSS2 P07478 3/20 0.49
PRSS3 P35030 3/20 0.49
ALDH1A1 P00352 5/20 0.42
NPSR1 Q6W5P4 1/20 0.36
KMT2A Q03164 3/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 2/20 0.34
PPARG P37231 1/20 0.34
NR2E3 Q9Y5X4 1/20 0.34
NCOR2 Q9Y618 1/20 0.34
TP53 P04637 2/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NOTUM Q6P988 1/20 0.33
USP2 O75604 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6931908 0.83 F2 (0.56) F2F10PLATPRSS1PRSS2
SCHEMBL6930600 0.75 F2 (1.00) F2F10PLATPRSS1PRSS2
Hydrochloric Acid SCHEMBL6929471 0.75 F2 (0.98) F2F10PLATPRSS1PRSS2
Hydrochloric Acid SCHEMBL6929473 0.70 F2 (0.55) F2F10PLATPRSS1PRSS2
SCHEMBL5330184 0.69 ALDH1A1 (0.58) F2ALDH1A1NPSR1KMT2AKDM4E
SCHEMBL30084182 0.69 ALDH1A1 (0.58) F2ALDH1A1NPSR1KMT2AKDM4E
SCHEMBL4927896 0.68 ALDH1A1 (0.53) F2ALDH1A1NPSR1KMT2AKDM4E
SCHEMBL6929890 0.68 F2 (1.00) F2F10PLATPRSS1PRSS2
SCHEMBL29236645 0.67 LOXL2 (0.40) ALDH1A1KMT2AKDM4EMEN1TP53
SCHEMBL16144650 0.67 ALDH1A1 (0.54) F2ALDH1A1NPSR1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030225131-A1 Thrombin inhibitors BURGEY CHRISTOPHER S (US) 2003-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225131-A1 Thrombin inhibitors TFPI, SERPINC1, PLAT F2 5/4885F10 27/4885PLAT 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.